The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis.
about
Anticholinergic drugs versus placebo for overactive bladder syndrome in adultsA small-animal pharmacokinetic/pharmacodynamic PET study of central serotonin 1A receptor occupancy by a potential therapeutic agent for overactive bladderAdverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approachA meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder.Medical management of overactive bladderThe placebo effect in overactive bladder syndrome.Single compartment drug delivery.Efficacy and safety of ginger-salt-indirect moxibustion for urge urinary incontinence after stroke: protocol for a pilot multicentre randomised controlled trial.Efficacy and safety of Baweidihuang-wan in women with overactive bladder: a randomized, double blind, placebo controlled trialMenthol inhibits detrusor contractility independently of TRPM8 activationMuscarinic receptors in the bladder: from basic research to therapeutics.Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trialAn overview of the clinical use of antimuscarinics in the treatment of overactive bladderBladder dysfunction in diabetes mellitus.Postmenopausal overactive bladderA comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder.Adipose derived stem cells ameliorate hyperlipidemia associated detrusor overactivity in a rat modelPercutaneous tibial nerve stimulation: a clinically and cost effective addition to the overactive bladder algorithm of care.A review and additional post-hoc analyses of the incidence and impact of constipation observed in darifenacin clinical trialsBenign prostatic hyperplasia. Part 2--management.The overactive bladder: review of current pharmacotherapy in adults. Part 1: pathophysiology and anticholinergic therapy.Cost implications of antimuscarinic drugs in the treatment of overactive bladder syndrome.Developments in pharmacological therapy for the overactive bladder.The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis.Solifenacin provides effective antimuscarinic therapy for the complete management of overactive bladder.The challenge of overactive bladder therapy: alternative to antimuscarinic agents.Botulinum toxin for treatment of urinary incontinence due to detrusor overactivity: a systematic review of effectiveness and adverse effects.PDE5 inhibitors beyond erectile dysfunction.Overactive bladder - 18 years - Part IINeurotoxin treatments for urinary incontinence in subjects with spinal cord injury or multiple sclerosis: a systematic review of effectiveness and adverse effects.Transdermal oxybutynin in the treatment of overactive bladder.Tolterodine for the treatment of overactive bladder.Current issues in the management of female urinary incontinence.Lower urinary tract symptoms in women-a common but neglected problem.Efficacy and safety of low-dose anticholinergics to treat men with lower urinary tract symptoms with overactive bladder: a retrospective study based on real life practice.Use of symptom-relieving drugs before and after surgery for urinary incontinence in women: a cohort study.Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin.Expert Panel Recommendations on Lower Urinary Tract Health of Women Across Their Life Span.Incidence and risk factors of recurrence of overactive bladder symptoms after discontinuation of successful medical treatment.Effect of imidafenacin on the urodynamic parameters of patients with indwelling bladder catheters due to spinal cord injury.
P2860
Q24243870-3B606CB1-2552-46B3-976E-46EF84FDC46FQ28533727-749ACCC3-D382-4CDF-888D-EB1F9112CCCCQ28742444-7494C23D-BB02-479E-B956-3F1D317EABA1Q33485538-5BD768D3-B6D2-405B-A442-77E75835CA78Q34124065-BF8FE8E1-0C5E-4AB2-8426-BE3B275C6BE3Q34197411-FD6C7F77-339E-4B85-944F-BD0C3BC9383CQ34263907-9087FEB5-CBF3-4518-9230-4B0312B754B2Q34397227-6292F606-F7AA-49E7-96D3-F52AD0F45B51Q34415046-EC735299-67BF-4CBA-82D7-E43BE27DDECEQ34465839-D0B721D3-E40D-4889-8C3D-04813544B33FQ34564708-1AA70520-39BB-4C01-A164-302876AD3B05Q34991783-B95C996F-1DA0-4F59-A362-AE21B508875CQ35042575-DFC87841-E085-44B8-B3E3-0275D3196E4CQ35155238-0D2E071E-C7AA-47D4-BF2F-4E570C59E448Q35157329-B9E9E703-9C2A-43C8-9BBA-C51291B19E60Q35183619-F139A5FC-380D-4A26-BB57-48F3E4746075Q35185998-AA9AC38D-EBA6-4949-AC15-55211A174CB7Q36223634-0242E620-78A4-4152-86A0-478BE1F54D76Q36307893-D56C4903-07F7-4CFC-A990-404A3A9BD624Q36405351-0BAFA3ED-B7E5-4779-8109-0097E094A0C2Q36428471-768DE4CA-16CC-47B7-A6CE-9086076BD057Q36428481-1812AFEE-A3F0-4274-BBC4-D438B47D7BC0Q36566857-BC6EF444-1A52-4E16-B850-65049FFE2632Q36616619-3FF30427-ECB4-4D3C-9D7F-9E3773F98291Q36655193-599CDF88-EAB8-4BAF-A115-FAED068B3EBFQ36698662-E065FFC3-C8F3-4EBC-BC4A-7D613D6B6B12Q36799110-8BDB36C6-FD24-4403-8825-57CBBA6B2267Q36878017-2D3C6641-1D44-472A-99E1-B00013A5420DQ36912766-C0D98024-CDD9-4E12-B966-85E76093E8ABQ36932034-808991CE-B5F6-44F0-A814-84C7AE5FA468Q37017359-F2EAE9FD-B484-4BF9-BCD3-B112588D901BQ37142090-0D73D1D3-D736-466C-8BF2-1690B69765CBQ37192368-B3CC308D-EE4B-43BA-B41D-91DA21294BABQ37202902-0086DFBE-756E-4A2A-B8AE-67CBF5507394Q37291029-A9BE7591-4DCB-4BF7-BC1C-DA485EE31114Q37342424-986769AA-2E92-41A8-9519-D5E2842ABFCCQ37405499-80029AFE-9996-4331-90B6-9B82CEE4A46BQ37424934-B70B7017-F1EF-48E1-9271-D957A4CC39FEQ37589167-60FD6C4C-0348-4D56-8FD8-0D3E5C273137Q37641107-129C6C58-D575-4B0D-8FAA-89083A96DC79
P2860
The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The effects of antimuscarinic ...... atic review and meta-analysis.
@ast
The effects of antimuscarinic ...... atic review and meta-analysis.
@en
type
label
The effects of antimuscarinic ...... atic review and meta-analysis.
@ast
The effects of antimuscarinic ...... atic review and meta-analysis.
@en
prefLabel
The effects of antimuscarinic ...... atic review and meta-analysis.
@ast
The effects of antimuscarinic ...... atic review and meta-analysis.
@en
P2093
P1433
P1476
The effects of antimuscarinic ...... atic review and meta-analysis.
@en
P2093
Julie Ann Dooley
Vik Khullar
Zahava Gabriel
P356
10.1016/J.EURURO.2005.02.024
P407
P577
2005-03-22T00:00:00Z